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RESEARCH ARTICLE

Longitudinal assessment of dementia measures in Down
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Abstract
Introduction: Early detection of dementia symptoms is critical in Down syndrome
(DS) but complicated by clinical assessment barriers. The current study aimed to char-
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acterize cognitive and behavioral impairment using longitudinal trajectories comparing
several measures of cognitive and behavioral functioning.
Methods: Measures included global cognitive status (Severe Impairment Battery
[SIB]), motor praxis (Brief Praxis Test [BPT]), and clinical dementia informant ratings
(Dementia Questionnaire for People with Learning Disabilities [DLD]). One-year reliability was assessed using a two-way mixed effect, consistency, single measurement
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intraclass correlation among non-demented participants. Longitudinal assessment of
SIB, BPT, and DLD was completed using linear mixed effect models.
Results: One-year reliability (n = 52; 21 male) was moderate for DLD (0.69 to 0.75)
and good for SIB (0.87) and BPT (0.80). Longitudinal analysis (n = 72) revealed significant age by diagnosis interactions for SIB (F(2, 115.02) = 6.06, P = .003), BPT (F(2,
85.59) = 4.56, P = .013), and DLD (F(2, 103.56) = 4.48, P = .014). SIB progression (PR)
had a faster decline in performance versus no-dementia (ND) (t(159) = −2.87; P =
.013). Dementia had a faster decline in BPT performance versus ND (t(112) = −2.46;
P = .041). PR showed quickly progressing scores compared to ND (t(128) = −2.86;
P = .014).
Discussion: Current measures demonstrated moderate to good reliability. Longitudinal analysis revealed that SIB, BPT, and DLD changed with age depending on diagnostic
progression; no change rates were dependent on baseline cognition, indicating usefulness across a variety of severity levels in DS.
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INTRODUCTION
RESEARCH IN CONTEXT

There is a clear connection between dementia, especially Alzheimer’s
1. Systematic review: Early detection of dementia is com-

disease (AD), and aging in people with Down syndrome (DS). Almost all

plicated by inherent clinical assessment barriers for indi-

individuals with DS from their mid-30s on have neuropathology con-

viduals with Down syndrome (DS) including intellectual

sistent with AD including amyloid plaques and neurofibrillary tangles.1

disability (ID), large intra- and inter-individual variability,

Notably, pathological changes have been documented in individuals

identification of appropriate baseline levels of function-

with DS as young as 20 years of age, or ≈50 years earlier than in
neurotypical aging

groups.2–4

ing, selection of tests with appropriate cut scores, and

This acceleration of pathology is likely

patient tolerability of testing. The current study aimed

related to the location of the APP gene and other overexpressed genes

to characterize the degree of cognitive and behavioral

on chromosome 21, which is triplicated in individuals with DS.1,5–7 In

impairment using longitudinal cognitive trajectories com-

addition to triplicated APP, individuals with DS have additional AD risk

paring several measures of cognitive and behavioral func-

factors including oxidative damage, neuroinflammation, higher rates of

tioning.

apolipoprotein E ε-4 allele (APOE ε4/ε4, ε4/ε3, ε4/ε2), propensity for

2. Interpretation: Measures of global cognitive status,

sleep apnea, and premorbid intellectual disabilities.1,5,8,9

motor praxis, and clinical dementia informant ratings

Improved medical care has resulted in an increased mean life

demonstrated moderate to good 1 year reliability. Lon-

expectancy for individuals with DS to age 53, with more than 70% living

gitudinal analysis revealed that these measures changed

past the age of 30 years and 20% living past 55 years.5,10,11 Together

with age depending on diagnostic progression and were

with increased lifespan, the factors above contribute to greater AD risk

not dependent on baseline level of ID, indicating their

in adults with DS than in other populations with intellectual disabilities or the general population.12

usefulness across a variety of ID levels in DS.

Between the ages of 30 and 39 ≈3.4%

3. Future Directions: Future research should compare the

of individuals with DS are diagnosed with dementia; however, research

current cognitive measures to biomarkers including neu-

suggests that vulnerability to atypical aging begins around age 35,2,13

roimaging, blood biomarkers, and other physiological

and dementia prevalence increases to 40% between the ages of 50 and
59.14,15

indicators of neurodegeneration in a longitudinal fashion

Given the exponential increase in AD-related neuropathology

to further validate and enhance sensitivity to dementia-

and dementia diagnosis, it is essential to detect early pathological and

related cognitive changes in DS.

cognitive AD changes to enhance clinical intervention and long-term
care for individuals with concurrent DS and dementia.

1.1

Detection of incipient AD in DS

measures used for diagnosing MCI and dementia in typical aging adults
are often inappropriate for use in DS populations given pre-existing

With enhanced technology and understanding of disease progres-

ID.18 Moreover, few measures have established cut scores for use in

sion, research has increasingly focused on detection of early cogni-

DS.19

tive and behavioral changes. Notably, individuals with DS and prodromal AD demonstrate early behavioral changes that appear comparable
to those of neurotypical adults with mild cognitive impairment (MCI).

1.2

Utility of cognitive measures

Specifically, behavioral changes such as delusions and violent outbursts
(either physical or verbal) appear more prevalent in adults with DS

Recent efforts within the field have focused on determining the util-

early in dementia while nighttime confusion, agitation, wandering, and

ity of cognitive measures in detecting prodromal dementia and AD in

visual hallucinations are more prominent in later stages.16 Such behav-

adults with DS. For instance, Walsh et al.20 examined cognitive mark-

ioral changes are generally accessible and easily studied in individuals

ers in 114 individuals with DS, 62% of whom carried dementia diag-

with DS given availability of informant ratings.

noses, in an attempt to validate the Rapid Assessment of Developmen-

Unfortunately, the onset and course of cognitive changes in individ-

tal Disabilities (RADD) for use in dementia diagnostics. RADD scores

uals with DS and AD remains less clear. Early detection of cognitive

were compared to performances on the Brief Praxis Test (BPT), Severe

changes in individuals with DS is complicated by the inherent difficulty

Impairment Battery (SIB), and Dementia Scale for People with Learning

of assessing cognition in the context of moderate to severe intellectual

Disabilities (DLD). Results indicated strong correlations between the

disability (ID). Additional assessment difficulties within this popula-

RADD and BPT (r = 0.842), SIB total (r = 0.921), and DLD sum of cogni-

tion include large intra- and inter-individual variability in cognition and

tive subscale scores (r = 0.889) indicating strong content concordance

behavior, differential diagnostic methods, identification of an appropri-

between measures.20

ate baseline, selection of a meaningful control group, and tolerability of

Further research on the SIB indicates a strong association in SIB

the testing process. Despite recent reports (Firth et al.17 ), a “gold stan-

total scores between persons with AD in the general population and

dard” neurocognitive battery has not been established, especially as

those with concurrent DS and dementia once adjusted for sex and

3 of 8

KOEHL ET AL .

functional impairment.21 Both the SIB and DLD have longstanding
established reliability and

validity,22,23

with such evidence supporting

mental changes that made consensus diagnosis undeterminable. Thus,
72 participants were included in the longitudinal analysis.

the appropriateness of using the SIB as a domain-based, yet brief,
assessment of cognitive change in DS.

2.2
1.3

Longitudinal assessment

Assessments

Clinical assessments included the BPT, SIB, and DLD. The BPT26 is a
measure of dyspraxia that is a modification of the original 62-item Dys-

Few studies have tracked longitudinal cohorts in an attempt to monitor

praxia Scale for Adults with Down Syndrome. The BPT consists of 20

cognitive changes and address the utility of specific cognitive measures

items selected from the original for maximum change demonstrated

al.24

over 3 years.27 The BPT requires minimal verbal demands and instead

followed 77 women with DS over a 14-year period with annual vis-

uses simple behavioral output. Low scores on the BPT indicate severe

its. Notably, the DLD appeared particularly sensitive to early and pro-

dyspraxia. The SIB28 was developed to assess cognition in severely

gressive cognitive change over time; this was in direct contrast to the

impaired individuals. By using one-step commands and gestural cues,

Down Syndrome Mental Status Examination (DSMSE), which appeared

the SIB allows for non-verbal responses and partially correct responses

less sensitive and best suited for those with less severe levels of ID.24

to assess behavioral and cognitive symptoms in individuals with severe

Despite the availability of only limited longitudinal data, researchers

dementia. The SIB yields a total score along with six major subscales

and clinicians alike understand the importance of early and regular cog-

including attention, orientation, language, memory, visuospatial abil-

nitive screening. Clinically, longitudinal measurement has gained trac-

ity, and construction; lower scores indicate more severe deficits. The

tion as a means of early AD detection, beginning with a baseline evalu-

DLD22 is a diagnostic screening tool that measures behavioral and cog-

ation at age 35 and with follow-ups annually or as needed.25

including the SIB, BPT, and DLD. In one such study, McCarron et

However,

nitive dysfunction as reported by caregivers or guardians. It consists

to the authors’ knowledge, no studies to date have empirically exam-

of 50 items resulting in a sum of cognitive scores including: short-term

ined the longitudinal trajectories and clinical utility of the BPT, SIB, and

memory, long-term memory, and spatial/temporal orientation along

DLD in a diverse cohort of individuals with DS.

with a sum of social scores including speech, practical skills, mood,

The Aging in Down Syndrome Study (ADS) at the University of Ken-

activity/interest, and behavioral disturbance. Higher scores on the DLD

tucky currently follows one such unique cohort. The present analyses

indicate more severe deterioration. DLD raters for the current study

examined longitudinal cognitive and behavioral symptoms from base-

were caregivers and/or legal guardians who were responsible for daily

line through conversion to and progression of AD using the BPT, SIB,

care of the participants either in the home or an assisted living setting.

and DLD. Several models were tested including whether rate of change
was dependent on time, age, baseline ID level, and diagnosis for each
of these measures. It was hypothesized that rate of change on all mea-

2.3

Consensus diagnosis

sures would be greater with time accrual and increased age at baseline diagnosis. While lower ID baselines were hypothesized to be asso-

Dementia diagnoses were determined through an expert diagnostic

ciated with initially lower baseline scores, rate of change over time was

consensus review consisting of one neuropsychologist, one psycholo-

hypothesized to be independent of ID status.

gist, and three neurologists and are based on NINCDS-ADRDA criteria. Baseline levels of ID were determined by caregiver report of prior
evaluation results and by review of records when available.

2

METHODS

2.1

Participants

2.4

Statistical analysis

Research procedures were approved by the University of Kentucky

A two-way mixed effect, consistency, single measurement intraclass

Institutional Review Board. Participants completed approved proto-

correlation (ICC[3,1]) was calculated for the SIB, BPT, and DLD. The

cols for informed consent or assent with guardian approval. Partici-

objective was to quantify the reliability of primary cognitive and

pants were community residing men and women with DS recruited

dementia outcome scales over a 1-year period among non-demented

through local DS support groups and residential facilities primarily in

(ND) individuals with DS. Reliability was considered poor if the ICC

Kentucky, southern Indiana, and southern Ohio.

was <0.5, moderate if ICC was between 0.5 and 0.75, good if the ICC

Participants were included in the test–retest reliability analysis if

was between 0.75 and 0.9, and excellent if ICC was >0.90.29 All anal-

they had a neuropsychological evaluation and were stable with no

yses were completed using R 3.6.130 and the “irr” package.31 Reliable

dementia at both years. There were 52 participants who were included

change indices were calculated using the methods described by Jacob-

in the analysis. For the longitudinal analysis 95 participants had more

son and Truax32 along with Chelune et al.33 These indices reflect the

than one visit. Participants were excluded (n = 23) from the longitudi-

amount of change in each assessment needed to be 90% or 95% confi-

nal analysis if they had other ongoing medical conditions or environ-

dent the change is beyond normal variability.

4 of 8

TA B L E 1

KOEHL ET AL .

Participant characteristics for test–retest reliability

3

Year 1 and 2 (N = 52)
% (n)

Mean (SD)

3.1

Median [Q1–Q3]

Sex

RESULTS
Test–retest reliability

Between years 1 and 2 there were 52 eligible participants who had SIB,

Male

40.38% (21)

Female

59.62% (31)

BPT, or DLD data. Of these 49 participants, 42 to 43 participants had
data for each specific test. Full participant characteristics are included

ID level

in Table 1. Results of the reliability analyses are reported in Table 2. SIB

Borderline

3.85% (2)

and BPT test–retest reliability over the first year of assessment was

Mild

55.77% (29)

good. DLD total score and subscore reliability was moderate. DLD cog-

Moderate

38.46% (20)

nitive subscore reliability had slightly better reliability than DLD social

Profound

0% (0)

Severe

0% (0)

subscore (Table 2). Reliable changes indices revealed that over the first
year, a decrease of 12 points on the SIB and of 10 points on the BPT
were associated with 90% confidence that a real change occurred. On

Not documented 1.92% (1)

the DLD, increases of 11 points in the total score, 7 points in the cog-

Age

38.96 (9.28)

37.06 [32.66–44.75]

Time (years)

1.02 (0.10)

1.02 [0.98–1.05]

SIB total

82.21 (15.92) 87 [73.50–94]

BPT total

69.60 (8.79)

DLD total

nitive subscore, and 6 points in the social subscore were associated
with 90% confidence of real change. More conservative reliable change
indices (at 95% confidence) are provided in Table 2.

72 [64.50–76]

9.77 (8.38)

7 [3–14.5]

DLD cognitive

4.44 (5.64)

2 [0–6]

DLD social

5.33 (4.25)

5 [2–8]

3.2

Abbreviations: BPT, Brief Praxis Test; DLD, Dementia Questionnaire for
People with Learning Disabilities; ID, intellectual disability; SD, standard
deviation; SIB, Severe Impairment Battery.

Longitudinal analysis

There were 72 participants (n = 32 male) who were eligible for the longitudinal analysis. About 64% of participants had four or fewer followup visits, the remainder having five or more, for an average number of
4.35 visits and follow-up time of 3.53 years. Full participant character-

Longitudinal analysis of SIB, BPT, and DLD was completed using

istics are provided in Table 3.

mixed effects models. The objective of this analysis was to evaluate the
rate of change in the SIB, BPT, and DLD across ages for participants
who remained ND versus those who progressed to dementia (PR), ver-

3.2.1

Brief praxis test

sus those who had dementia as baseline (DM). First, the random effects
were specified using the restricted likelihood method. Random inter-

Age (F(1,94.51) = 10.03; P = .002), ID level (F(1,60.10) = 7.35; P =

cept versus random intercept and slope models were compared. The

.009), and diagnosis progression (F(2, 70.26) = 11.33; P < .001) were

random intercept model was selected as there were no issues with con-

all found to be significantly associated with BPT total score. Sex was

vergence. Then main effects and interactions of the fixed effects (eg,

not significantly associated with BPT total score and was dropped from

age and disease progression) were fitted using the maximum likelihood

the model. For each year increase in age, BPT scores dropped 0.40

method. Post-hoc comparisons used the Tukey correction for multiple

points (t(94.51) = −3.17; P = .002). Individuals with moderate to pro-

comparisons. Model fit was selected based on loglikelihood of nested

found ID scored 5.79 points lower than those with borderline/mild ID

models, Akaike information criterion (AIC), and Bayesian information

(t(60.10) = −2.71; P = .009). Using a Tukey correction for multiple

criterion (BIC). All analyses were completed using R 3.6.130 and the

comparisons, individuals with DM had significantly lower BPT scores

“lme4”34 and “lmerTest”35 packages.

than the ND (difference = −12.36; t(93.50) = −3.32; P = .004) or

TA B L E 2

Summary of test–retest reliability and reliable change indices
n

Time 1 mean (SD)

Time 2 mean (SD)

ICC (95% CI)

90% RCI

95% RCI

SIB

43

84.16 (15.00)

86.37 (11.75)

0.87 (0.77–0.93)

12

14

BPT

42

70.57 (9.09)

70.98 (8.71)

0.80 (0.66–0.89)

10

11

DLD

43

8.98 (8.09)

9.19 (8.38)

0.71 (0.53–0.83)

11

13

DLD – Cognitive

43

3.86 (5.19)

4.33 (6.19)

0.75 (0.58–0.86)

7

8

DLD – Social

43

5.12 (4.44)

4.86 (4.09)

0.69 (0.49–0.82)

6

7

Note: RCI values were rounded up to next whole number.
Abbreviations: BPT, Brief Praxis Test; DLD; ICC, intraclass correlation; RCI, reliable change index; SD, standard deviation; SIB, Severe Impairment Battery.

5 of 8

KOEHL ET AL .

TA B L E 3

Participant characteristics for longitudinal analysis
% (n)

Mean (SD)

Median [Q1–Q3]

Sex
Male

44.44% (32)

Female

55.56% (40)

3.2.2

Severe impairment battery

Age (F(1,127.77) = 6.77; P = .010), ID level (F(1,67.52) = 11.22; P =
.001), and diagnosis progression (F(2, 78.83) = 6.69; P = .002) were
all found to be significantly associated with SIB total score. Sex was
not significantly associated with SIB total score and was dropped from

ID level

the model. For each year increase in age, SIB scores dropped 0.48

Borderline/mild

48.61% (36)

points (t(127.77) = −2.60; P = .010). Individuals with moderate to pro-

Moderate to
profound

47.22% (34)

found ID scored 11.30 points lower than those with borderline/mild ID

Not documented

1.39% (1)

(t(67.53) = −3.35; P = .001). Using a Tukey correction for multiple comparisons, individuals with DM had significantly lower SIB scores than
the ND (difference = −18.06; t(97.50) = −3.19; P = .005) or PR (dif-

Baseline diagnosis
No dementia

72.22% (52)

ference = −16.75; t(80.50) = −3.17; P = .006) cohorts. There was no

Possible dementia

9.72% (7)

significant difference between the ND and PR groups (P > .05).

Probable dementia

18.06% (13)

Next, a model examining the interaction of age and diagnosis progression was examined. The interaction model provided better fit than

Last diagnosis

the main effects model based on AIC, BIC, and likelihood ratio test.

No dementia

56.94% (41)

Possible dementia

9.72% (7)

gression status (F(2, 115.02) = 6.06; P = .003). Using a Tukey correc-

Probable dementia

33.33% (24)

tion for multiple comparisons, the PR group had a significantly faster

Thus, the change in SIB scores across age depended on diagnosis pro-

decline in SIB performance compared to the ND cohort (t(159) =

Diagnosis progression
Remained
non-Demented

53.94% (41)

Progressed

23.61% (17)

Dementia at
baseline

19.44% (14)

−2.87; P = .013), but the DM group did not (t(118) = −2.35; P = .052).
There was no significant difference between the DM and PR groups
(P > .05; Figure 1B).

Follow-up (years)

3.53 (2.28)

2.91 [1.93–5.38]

Age

41.31 (10.57) 39.50 [33–50]

SIB total

79.64 (19.06) 87 [70–93]

BPT total

67.80 (11.71) 71.50 [63–76]

DLD total

15.10 (13.59) 11 [4–21]

DLD cognitive

7.52 (8.72)

4 [1–14]

DLD social

7.58 (6.10)

6 [3–11]

Abbreviations: BPT, Brief Praxis Test; DLD, Dementia Questionnaire for
People with Learning Disabilities; ID, intellectual disability; SD, standard
deviation; SIB, Severe Impairment Battery.

3.2.3
Dementia questionnaire for people with
learning disabilities
Age (F(1,110.03) = 4.56; P = .035) and diagnosis progression (F(2,
76.26) = 23.52; P < .001) were found to be significantly associated
with SIB total score. Sex and ID level were not significantly associated
with DLD total score and were dropped from the model. For each year
increase in age, DLD scores increased 0.33 points (t(110.03) = 2.14;
P = .035). Using a Tukey correction for multiple comparisons, individuals with PR (difference = 11.00; t(82.00) = 2.87; P = .014) or DM (difference = 29.60; t(90.30) = 6.63; P < .001) had significantly higher DLD
scores than ND. Furthermore, those with DM had elevated DLD scores

PR (difference = −15.74; t(83.00) = −4.54; P < .001) cohorts.

compared to the PR group (difference = 18.50; t(76.00) = 4.53; P <

There was no significant difference between the ND and PR groups

.001).

(P > .05).

Next, a model examining the interaction of age and diagnosis pro-

Next, a model examining the interaction of age and diagnosis pro-

gression was examined. The interaction model provided better fit than

gression was examined. The interaction model provided better fit than

the main effects model based on AIC and likelihood ratio test. BIC

the main effects model based on AIC and likelihood ratio test. BIC was

was not smaller in the interaction compared to the main effect model.

not smaller in the interaction compared to the main effect model. Thus,

Thus, the change in DLD scores across age depended on diagnosis pro-

the change in BPT scores across age depended on diagnosis progres-

gression status (F(2, 103.56) = 4.48; P = .014). Using a Tukey correc-

sion status (F(2, 85.59) = 4.56; P = .013). Using a Tukey correction for

tion for multiple comparisons, the PR group had a significantly faster

multiple comparisons, the DM group had a significantly faster decline

increase in DLD score compared to the ND cohort (t(128) = −2.86; P =

in BPT performance compared to the ND cohort (t(112) = −2.46; P

.014). There was no significant difference between the DM and PR or

= .041), but the PR group did not (t(112) = −2.03; P = .109). There

ND groups (both P values > 0.05; Figure 1C). However, there was a

was no significant difference between the DM and PR groups (P > .05;

main effect of diagnosis progression whereby the DM group had signif-

Figure 1A).

icantly higher DLD total scores than ND (difference = 31.08; t(103.00)
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F I G U R E 1 Predicted changes in primary outcome measures by age and progression status. A) BPT total score declined with increasing age at a
greater rate among those who had dementia from baseline (DM) compared to those who remained non-demented (ND); B) SIB total score declined
with increasing age at a greater rate among those who progressed (PR) compared to those who remained non-demented (ND); C) There were no
significant differences in rates of DLD change between groups, but there was a main effect of group whereby the DM group had significantly
higher DLD total scores than the ND and PR groups
= 5.59; P < .001) and PR (difference = 22.41; t(101.20) = 3.69; P = .001)

tical to previously suggested cutoff scores for the DLD and its sub-

groups (Figure 1C).

scales, supporting those estimates with a larger sample size and a more
extensive consensus process for group formation.22 Specifically, a 1year change in DLD Total Score of 11 points or more, in DLD Cognitive

4

DISCUSSION

score of 6 points or more, or in DLD Social score of 7 points or more represented meaningful change with 90% confidence. Furthermore, the

This study sought to characterize and compare over time the cog-

current study adds to the DS literature by determining that a 1-year

nitive trajectories of individuals with DS who remain non-demented,

change in SIB score of 12 points or more, or in BPT score of 11 points

those who progress to dementia, and those monitored after a

or more, reflect a meaningful change with 90% confidence. These repli-

dementia diagnosis. The approach was two-fold: (1) to estimate

cated and novel change indices help provide context for what is and is

test–retest reliability of a short battery using the subsample of

not a meaningful change.

individuals who remained non-demented over the course of the

Longitudinal changes in global mental status, praxis, and Clinical

1-year study period and (2) to estimate and compare rates of

Dementia Rating were generally in accordance with previous literature

change over time attributable to changes in clinical consensus

associating increased cognitive and functional impairment by various

diagnosis.

measures, including the DLD, with passage of time, age at baseline, and

Test-retest reliability estimates were acceptable for all three mea-

baseline level of ID.24 In the present study, BPT and SIB scores were

sures in the battery, with particularly good reliability for the SIB and

sensitive to baseline ID level, whereas DLD score was not. This may be

BPT. DLD test-retest reliability was moderate overall but was stronger

as expected for the DLD, which was designed explicitly to account for

for the cognitive subscale than the social subscale. The more objective,

developmental ID status, and for the SIB, which was not. More surpris-

task-oriented approach of SIB and BPT versus the more subjective,

ing is that the BPT was sensitive to baseline ID level despite its devel-

caregiver-rating approach of the DLD may explain these reliability

opment for use with individuals with DS. More crucially, the rate of

differences across measures, whereas DLD subscale differences in

change on all three of our clinical measures was independent of base-

reliability potentially stem from the additional subjectivity involved in

line ID status, demonstrating that longitudinal monitoring does amelio-

rating social behavior versus cognitive ability within the DLD. Overall,

rate the barrier that baseline ID presents to measurement of cognition

these estimates concord with prior studies and provide replication in

in the context of assessment for dementia. This time-dependent effect

an independent sample.22,23,36

demonstrates that the DLD, SIB, and BPT can detect changes in DS indi-

Moreover, the 90% confidence reliable change indexes computed
for use as a clinical tool to identify meaningful changes are nearly iden-

viduals across a variety of ID levels and therefore could be useful in a
clinic setting.
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Individuals with dementia at study onset had, in general, a faster

the predictive utility of reliable change indices. Furthermore, longitu-

decline than individuals who remained non-demented throughout.

dinal results revealed that the SIB, BPT, and DLD changed with age

However, trajectories for individuals who progressed from non-

depending on diagnosis progression across all levels of ID in DS. While

demented to dementia during the study were not different from the

the SIB and BPT demonstrated that individuals who progressed to

ND or DM groups despite trends to that effect (potentially due to

dementia or were demented from baseline had faster rates of decline,

the small sample size of this group). These findings suggest a limited

the DLD demonstrated the greatest separation in non-demented, pro-

utility of global mental status and praxis for early detection or pro-

gression, and demented cohorts.

dromal changes in contrast to much larger and complex cognitive
assessments (eg, Firth et al.17 and Startin et al.37 ). Ratings of clinical
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appear on rating instruments such as the DLD before mental status
and praxis measures such as the SIB and BPT. This result supports a
previous longitudinal study of cognitive decline in DS, indicating that
informant ratings may better detect executive and cognitive function
declines.39
Mental status and praxis measures showed the expected performance reductions across diagnostic categories, as well as the expected
decline over time in individuals with DS and comorbid dementia. They
were not, however, as sensitive to early changes of incipient dementia
as informant ratings. Relative sensitivity of the DLD to early changes
of incipient dementia compared to other measures may be due to a
number factors, including differences in instrument content, involvement of caregivers in the assessment process, or difficulty motivating
and engaging individuals with DS and possible dementia in the formal
assessment process, as well as floor or ceiling effects on the objective
measures used.
The present study has several limitations. Wide inter-individual
variability in performance on clinical assessments, even within diagnostic status and ID level, limits detection of reliable effects and likely
makes the clinical recommendations for identifying reliable change
in individual scores overly conservative. Considerable intra-individual
variability in performance on clinical assessments and in diagnostic status over time poses similar problems and urges further caution regarding generalizability of the present findings. Furthermore, due to the
recruitment limitations and high rate of loss to follow-up inherent in
studying this special population, sample sizes within diagnostic groups
are relatively small, and most participants have been enrolled for a relatively short time. Finally, data from the clinical battery were included in
the overall consensus adjudication of diagnoses, presenting the threat
of criterion contamination endemic to clinical dementia research. The
present cohort enrolls continuously, and future sample growth and
follow-up will mitigate the majority of these limitations. Ultimately, the
effect of criterion contamination will be addressed with additional validation against neuropathology found at autopsy.
The current study revealed moderate to good reliability of assessments for dementia in DS. Future prospective studies should evaluate
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